Status:
TERMINATED
The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A study from our group (Osterkamp et al. in preparation) used ICG to evaluate intraoperative changes in gastric perfusion when reducing the circulating blood volume by blood withdrawal in pigs. We saw...
Detailed Description
Screening Laparoscopy: As part of the standard care for gastric cancer, all patients undergo a screening laparoscopy before entering neoadjuvant chemotherapy. The procedure is performed to detect ove...
Eligibility Criteria
Inclusion
- Patients (above 18 years) scheduled for planned open or robot-assisted resection of gastric cancer.
Exclusion
- Allergy towards; iodine, indocyanine green or shellfish
- Severe liver insufficiency
- Thyrotoxicosis
- Nephropathy requiring dialysis
- Pregnancy or lactation
- Legally incompetent for any reason
- Withdrawal of inclusion consent
- Disseminated disease or other that contraindicates curative surgery
Key Trial Info
Start Date :
March 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT05354856
Start Date
March 11 2022
End Date
December 30 2023
Last Update
May 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, KBH Ø, Denmark, 2100